SCTB41 Plus SCTB39G With or Without Standard Therapy in Advanced Solid Tumors

NCT07665970 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

112

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Solid Tumors

Interventions

DRUG: SCTB41+SCTB39G

Sponsor

Sinocelltech Ltd.